R.P.M.C. S.à r .l.
Total Assets
€43K
Equity
€43K
Total equity, calculated from disclosed equity components.
Equity ratio
100%
Strong
Return on equity
0%
Adequate
Registered address
8, Rue Notre-Dame, 2240 Luxembourg
Activity (NACE 86.902)
Activities for human health not performed by hospitals or by medical doctors or dentists
Constituted
1 January 0001
Registered
25 April 2014
Legal form
Société à Responsabilité Limitée (S.à r.l.)
What this legal form means
Establishment number
B186397.0
Financials
Abridged Balance Sheet only · eCDF
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Net income | €13K | €13K | €9K | €3K |
| Equity | €43K | €29K | €12K | €17K |
| Total assets | €43K | €29K | €12K | €17K |
| Cash | €8K | €10K | €11K | €16K |
Establishments
- R.P.M.C. S.à r .l. principal 8, Rue Notre-Dame, 2240, Luxembourg
Filings
-
Update of the Luxembourg national identification number of natural persons registered with the RCS
Associate(s), Administrator(s)/Manager(s) 6 October 2025 -
Annual accounts (eCDF)
Exercise from 01/01/2024 to 31/12/2024 31 July 2025 -
Annual accounts (eCDF)
Exercise from 01/01/2023 to 31/12/2023 25 July 2024 -
Annual accounts (eCDF)
Exercise from 01/01/2022 to 31/12/2022 26 July 2023 -
Annual accounts (eCDF)
Exercise from 01/01/2021 to 31/12/2021 22 July 2022 -
Annual accounts (eCDF)
Exercise from 01/01/2020 to 31/12/2020 30 July 2021 -
Annual accounts (eCDF)
Exercise from 01/01/2019 to 31/12/2019 20 October 2020 -
Annual accounts (eCDF)
Exercise from 01/01/2018 to 31/12/2018 28 October 2019 -
Annual accounts (eCDF)
Exercise from 01/01/2017 to 31/12/2017 25 October 2018 -
Annual accounts (eCDF)
Exercise from 01/01/2016 to 31/12/2016 20 October 2017 -
Annual accounts (eCDF)
Exercise from 01/01/2015 to 31/12/2015 14 September 2016 -
Annual accounts (eCDF)
Exercise from 03/04/2014 to 31/12/2014 19 October 2015 -
Registration
- 25 April 2014
Request a company report
Ratios, peer benchmarks, risk scoring and a downloadable PDF for R.P.M.C. S.à r .l.. Tell us what you need and we will come back with scope and pricing.